Arrowhead Pharmaceuticals, Inc. 0HI3.L
0HI3.L
Arrowhead Pharmaceuticals, Inc. 0HKF.L
Axsome Therapeutics, Inc. 0VGI.L
TG Therapeutics, Inc. 0VQA.L
Viking Therapeutics, Inc. 0K1R.L
Viridian Therapeutics, Inc. 0Y5E.L
Perrigo Company plc 0A8E.L
Xeris Biopharma Holdings, Inc. 0EE0.L
uniQure N.V. 0JBU.L
Intellia Therapeutics, Inc. 0I0X.L
Codexis, Inc.
Arrowhead Pharmaceuticals, Inc. 0HKF.L
Axsome Therapeutics, Inc. 0VGI.L
TG Therapeutics, Inc. 0VQA.L
Viking Therapeutics, Inc. 0K1R.L
Viridian Therapeutics, Inc. 0Y5E.L
Perrigo Company plc 0A8E.L
Xeris Biopharma Holdings, Inc. 0EE0.L
uniQure N.V. 0JBU.L
Intellia Therapeutics, Inc. 0I0X.L
Codexis, Inc.
Performance
| Periode | 0HI3.L | 0HKF.L | 0VGI.L | 0VQA.L | 0K1R.L | 0Y5E.L | 0A8E.L | 0EE0.L | 0JBU.L | 0I0X.L |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 206.74 % | 25.87 % | 32.21 % | 37.53 % | 68.70 % | -12.69 % | 118.00 % | 361.99 % | 73.77 % | 19.64 % |
| YTD | 102.82 % | 50.11 % | 19.60 % | -16.68 % | 13.96 % | -16.62 % | 162.46 % | 262.12 % | 17.19 % | -46.08 % |
| 1Y | 94.35 % | 47.81 % | 53.67 % | -54.68 % | -5.89 % | -14.40 % | 184.20 % | 861.08 % | -13.27 % | -15.72 % |
| 3Y | 18.94 % | 213.51 % | 577.21 % | 694.48 % | 11.29 % | -34.30 % | 719.91 % | 248.51 % | -73.24 % | -54.19 % |
| 5Y | -47.44 % | 3 904.48 % | 207.56 % | 448.81 % | -19.30 % | -34.30 % | 719.91 % | 53.85 % | -85.26 % | -54.19 % |
| 10Y | 530.10 % | 3 904.48 % | 207.56 % | 133.88 % | -82.62 % | -34.30 % | 719.91 % | 239.53 % | -85.26 % | -54.19 % |
| From the beginning | 530.10 % | 3 904.48 % | 207.56 % | 133.88 % | -82.62 % | -34.30 % | 719.91 % | 239.53 % | -85.26 % | -54.19 % |